Advertisement
U.S. markets close in 5 hours 17 minutes

Aerovate Therapeutics, Inc. (AVTE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.5650+0.0350 (+1.39%)
As of 10:40AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.5300
Open2.5400
Bid2.5000 x 100
Ask2.6300 x 100
Day's Range2.5400 - 2.6400
52 Week Range1.2500 - 32.4150
Volume63,792
Avg. Volume772,889
Market Cap74.063M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.1300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.33
  • BioPharma Dive

    Jade, another biotech spinout of Paragon, to merge with Aerovate

    The immune disease drug developer expects to raise $300 million in a private financing set to close before its combination with the struggling Aerovate.

  • GlobeNewswire

    Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

    Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Jade Biosciences, the fourth company founded on assets licensed from Paragon Therapeutics, expects to initiate a clinical trial for JADE-001 in the second half of 2025 Approximately $300 million raised to date, including anticipated proceeds from an oversubscribed pre-closing private financing, expected to fund operations t